Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 172,352 | 23,680 | 0 | 0 | 139,709 |
| Cost of Goods | 6,970 | 826 | N/A | N/A | N/A |
| Gross Profit | 165,382 | 22,854 | N/A | N/A | 139,709 |
| Operating Expenses | 439,436 | 363,352 | 229,954 | 151,757 | 113,489 |
| Operating Income | -273,084 | -339,672 | -229,954 | -151,757 | 26,220 |
| Interest Expense | 35,062 | 5,177 | 361 | 3,137 | 1,899 |
| Other Income | 22,724 | 26,091 | 20,955 | 5,556 | 605 |
| Pre-tax Income | -285,422 | -318,758 | -209,360 | -149,338 | 24,926 |
| Net Income Continuous | -285,422 | -318,758 | -209,360 | -149,338 | 24,926 |
| Net Income | $-285,422 | $-318,758 | $-209,360 | $-149,338 | $24,926 |
| EPS Basic Total Ops | -3.29 | -3.72 | -2.98 | -2.46 | 0.48 |
| EPS Basic Continuous Ops | -3.29 | -3.72 | -2.98 | -2.46 | 0.48 |
| EPS Diluted Total Ops | -3.29 | -3.72 | -2.98 | -2.46 | 0.46 |
| EPS Diluted Continuous Ops | -3.29 | -3.72 | -2.98 | -2.46 | 0.46 |
| EPS Diluted Before Non-Recurring Items | -3.29 | -3.72 | -2.98 | -2.46 | 0.48 |
| EBITDA(a) | $-283,603 | $-353,102 | $-244,745 | $-155,106 | $26,907 |